SynthesisUpdates in surgery2021
The robotic single-port platform for gynecologic surgery: a systematic review of the literature and meta-analysis.
Synthesis in Updates in surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- A Systematic Review and Meta-Analysis of the Effectiveness and Cost of Single-Site Robotic Surgery and Single-Site Laparoscopic Surgery in Gynecological Diseases: The Era of Single-Site Robotic Surgery May Have Arrived.Cancer reports (Hoboken, N.J.) · 2025Pooled it
- Impact of Preoperative Ultrasound-Guided Rectus Sheath Block on Postoperative Recovery After Robot-Assisted Gynecologic Surgery: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- New access to intraluminal gastric pathologies: the SP da Vinci transgastric approach.Surgical endoscopy · 2026Article
- Clinical application and early experience of da Vinci Xi robotic single-site laparoscopic gynecologic surgery in mainland China: early experience from a retrospective consecutive cohort of 221 cases.International journal of surgery (London, England) · 2026Article
- Article
- Robotic platforms in gynaecological surgery: past, present, and future.Facts, views & vision in ObGyn · 2024Article
- A longitudinal study of symptom cluster latent profiles in ovarian cancer patients undergoing chemotherapy.Cancer medicine · 2024Article
- Feasibility and Surgical Outcomes of Hybrid Robotic Single-Site Hysterectomy Compared with Single-Port Access Total Laparoscopic Hysterectomy.Journal of personalized medicine · 2023Article
- The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence.Frontiers in surgery · 2022Article
- Can a single-port robot be safely used for robotic total gastrectomy for advanced gastric cancer? First experience using the da Vinci SP platform.Gastroenterology report · 2022Article
- Effect of Psychological Intervention on Pelvic Floor Function and Psychological Outcomes After Hysterectomy.Frontiers in medicine · 2022Article
- Analysis of Short-Term Efficacy of Gasless Single-Port Laparoscopic Inguinal Lymphadenectomy Through Vulva Incision for Vulvar Cancer.Frontiers in surgery · 2022Article
- Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Surgical Staging of Early-Stage Ovarian Cancers: A Report of Two Cases.Frontiers in surgery · 2022Article
- Early return to work: Single-port vs. multiport laparoscopic surgery for benign ovarian tumor.Frontiers in surgery · 2022Article
- Transvaginal natural orifice endoscopic surgery for myomectomy: Can it be a conventional surgery?Frontiers in surgery · 2022Article
- Robotic single-port platform for gynecologic surgery: indications, outcomes and challenges.Updates in surgery · 2021Article
- Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience.Frontiers in oncology · 2021Article
- Near-Infrared Imaging With Indocyanine Green for the Treatment of Endometriosis: Results From the Gre-Endo Trial.Frontiers in oncology · 2021Article
- Initial Outcomes and Methodologies of a Novel Single-Port Robotic Surgery in Gynecology.JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the first robotic single-site hysterectomy was performed, the research focused on the use of robotic single-site surgery (RSSS) for all gynecological conditions. This review aims to examine the studies available in the literature on RSSS in gynecology both for benign and malignant indications. The systematic review was carried out in agreement with the preferred reporting items for systematic reviews and meta-analyses statement (PRISMA). All the articles were grouped into three sets based on the surgical indication (Group 1, 2, and 3 for benign, malignant, and mixed diseases, respectively). Two hundred and fifty total studies were analyzed, and 27 articles were included in the review. A total of 1065 patients were included in the analysis. Of these, 605 patients were included in group 1, 260 in group 2, and 200 in group 3. Ten (1.7%) patients with benign pathology, 16 (6.2%) patients with malignant disease, and 5 (2.5%) patients with both diseases developed major complications. Two (0.3%) patients in group 1, 3 (1.2%) patients in group 2 and 5 (2.5%) in group 3 were converted to a different type of surgery. No significant differences were found between groups for BMI (p = 0.235), operative time (p = 0.723), estimated blood loss (EBL) (p = 0.342), and hospital stay (p = 0.146). The complications and conversions incidence through pooled analysis showed a higher general conversion rate (p = 0.012) in group 3 (3.0%) and higher complications rate (p = 0.001) in group 2 (5.3%) compared to the other groups. RSSS seems to be a feasible and safe procedure for all gynecological surgical procedures. A long-term analysis would be necessary before considering the RSSS oncologically safe for patients with malignant disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.